Navigation Links
Cepheid Announces Accelerated Development of Flu A Panel Test
Date:9/9/2009

SUNNYVALE, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced the accelerated development of a Flu A (Influenza Virus) Panel test for use on the GeneXpert((R)) System. The test will be designed to provide 45-minute identification of Flu A infection, with specific presumptive identification of seasonal H1, seasonal H3, and H1N1 novel strain types. Following review of the Request for Consideration for Emergency Use Authorization (EUA) by the U.S. Food & Drug Administration (FDA), the test is expected to be authorized for use during the upcoming influenza season, with product shipments beginning in January 2010.

"In reviewing the needs of the healthcare system, it became apparent that the GeneXpert is a key potential solution to the universal need for rapid and accurate flu testing on both a centralized and disseminated basis," said John Bishop, Cepheid's Chief Executive Officer. "In recognition of this universal need, we reprioritized longer term projects within the company in order to deliver this product in a timely manner."

Subsequent to the EUA request for consideration by the FDA, the test will be made available in Europe as a CE IVD product.

"Currently, laboratories do not have a rapid test to discriminate among the multiple influenza strains expected to be present this flu season -- each of which have different antiviral drug susceptibilities," said David Persing, MD, PhD, Cepheid's Executive Vice President, Chief Medical & Technology Officer. "To make this test available as quickly as possible, we plan to accelerate development by leveraging the work completed on a previous influenza project supported through a 2007 contract with the Department of Health and Human Services (HHS) and Centers for Disease Control and P
'/>"/>

SOURCE Cepheid
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Cepheid to Webcast Upcoming Financial Presentations
2. Cepheid Reports 2009 Second Quarter Results
3. Cepheid Receives FDA Clearance for First On-Demand Molecular Diagnostic Test for Clostridium difficile Infection
4. Cepheid Announces European Release of Improved Test for BCR-ABL Chromosomal Translocation Associated With Chronic Myelogenous Leukemia (CML)
5. Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference
6. Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
7. Blue Mountain Quality Resources Announces that Cepheid has Selected Blue Mountain Regulatory Asset Manager
8. Cepheid to Webcast Upcoming Financial Presentations
9. Cepheid Announces European Release of First On-Demand Molecular Pre-Surgical Screening Test for Simultaneous Detection of Methicillin-Sensitive and Resistant S. aureus
10. Cepheid Receives Health Canada License for First On-demand Diagnostic Test for Life-threatening MRSA and S. aureus Infections From Patient Positive Blood Culture Bottles
11. Cepheid Reports Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough technologies are now ... Dr. Lev Kalika, founder of New York Dynamic Neuromuscular Rehabilitation & Physical ... conservative treatment of back, hip, knee and shoulder pain as well as sports ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... (CVR) recently received nearly $4 million through five federal grants to study a ... therapies against the deadly diseases. , The research will be conducted in ...
(Date:7/2/2015)... ... July 02, 2015 , ... eHuman Digital ... new release of their flagship product, 3D Tooth Atlas, version 7.6. This release ... and new tutorial videos. This latest release of the 3D Tooth Atlas offers ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. ... been retained to lead a national chief executive officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/2/2015)... ... July 02, 2015 , ... After conducting a nationwide executive search ... Center in Yuma, Ariz., has hired Robert Trenschel, DO, as chief executive officer. ... Dr. Trenschel will assume his new duties at Yuma Regional Medical Center on July ...
Breaking Medicine News(10 mins):Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3
... Mary Dean, president and CCO of,KickSkirt, Inc., will ... help moms,improve the health of their children while ... M2Moms(TM) - The Marketing-To-Moms Conference,October 23-24, 2007, Chicago ... MD, founder and medical director of Peak Wellness ...
... Finds Minnesota,s Seniors Face Fourth Highest Shortfall,Nationally; ... Oct. 4 A new independent,analysis of the ... estimates states are under funding the actual cost ... least $4.4 billion,annually -- representing a dramatic 45 ...
... approvals are being recorded, but backlog continues to grow, ... -- Despite improved handling of generic drug applications and ... a rising tide of requests for approvals, officials said ... 682 generic drugs, an increase of 33 percent from ...
... from the,University of Wisconsin comparing optical colonoscopy to ... Medicine today raises several,important issues for the public ... the abdomen. "Gastrointestinal physicians are committed to,preventing colorectal ... all of us on the front lines of ...
... October 4, 2007 A group working at the ... with the University of Pavia has discovered that telomeres, ... that progressively shorten every time a cell divides, also ... Science Express, calls into question our understanding of how ...
... WASHINGTON, Oct. 4 In a departure from,current ... encouraged,pregnant women and women of childbearing age to ... mercury, a highly potent,neurotoxin and other contaminants commonly ... pregnant women to eat more fish without,mentioning the ...
Cached Medicine News:Health News:Brands Tackle the Childhood Obesity Issue During M2Moms(TM) - The Marketing-To-Moms Conference 2Health News:New National Medicaid Study: Minnesota Under Funds Seniors' Nursing Home Care $167 Million Annually 2Health News:New National Medicaid Study: Minnesota Under Funds Seniors' Nursing Home Care $167 Million Annually 3Health News:FDA Struggles to Keep Pace With Requests for Generics 2Health News:FDA Struggles to Keep Pace With Requests for Generics 3Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 2Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 3Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 4Health News:New telomere discovery could help explain why cancer cells never stop dividing 2
(Date:7/2/2015)... , July 2, 2015  New product launches are ... leading role in educating thought leaders about new products, ... heavily influence how well a new therapy performs at ... from research and consulting leader Best Practices, LLC, critical ... to focus on are early stage thought leader (TL) ...
(Date:7/2/2015)... July 2, 2015 Releases of ... Aedes aegypti , , reduced the dengue ... Brazil by 95%, well below the modelled ... http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal PLOS Neglected Tropical ... Oxitec,s genetically engineered mosquitoes. The results showed that in ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) ... by Analog, Application, End-User & by Region - Global Trends ... This market is projected to reach about $2.5 Million ... applications and rising opportunities in countries such as ... Italy , and Brazil . In ...
Breaking Medicine Technology:Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... Inc. (Nasdaq: PCYC ), announced today ... with Janssen Biotech, Inc., one of the Janssen ... to develop and commercialize PCI-32765, a novel, oral, ... for the treatment of Non Hodgkin,s Lymphoma, Chronic ...
... LLC , an established CRO providing clinical research services in ... biopharmaceutical industry, announced today that it is being featured in ... Terry Bradshaw.  According to the episode, it ... to launch a new drug, and even then, only one ...
Cached Medicine Technology:Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc. 2Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc. 3Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc. 4ClinStar to Be Featured on Business Day TV With Terry Bradshaw 2
... has been developed specifically to fight Cellulite ... and hips. It does this by stimulating ... fluids in your body, which then are ... daily, for about 15 minutes each treatment. ...
A device combining the "palpate & roll technique to vacuum massage, innovation dedicated to efficiency....
... Midmarks 604 Manual ExamTable was ... patient in mind and gives you ... available. However, this cost-effective table does ... the new 604, the physician can ...
... The Midmark 622 and 623 High-Low Examination ... ,patients, staff and you. Many different types ... a ,physicians office how to get on the ... an exam table ,can increase a patients comfort ...
Medicine Products: